<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR174">
 <label>174.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gasparian</surname>
    <given-names>A. V.</given-names>
   </name>
   <name>
    <surname>Neznanov</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Jha</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Galkin</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Moran</surname>
    <given-names>J. J.</given-names>
   </name>
   <name>
    <surname>Gudkov</surname>
    <given-names>A. V.</given-names>
   </name>
   <name>
    <surname>Gurova</surname>
    <given-names>A. V.</given-names>
   </name>
   <name>
    <surname>Komar</surname>
    <given-names>A. A.</given-names>
   </name>
  </person-group>
  <article-title>Inhibition of encephalomyocarditis virus and poliovirus replication by quinacrine: implications for the design and discovery of novel antiviral drugs</article-title>
  <source>J. Virol.</source>
  <year>2010</year>
  <volume>84</volume>
  <fpage>9390</fpage>
  <lpage>9397</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.02569-09</pub-id>
  <?supplied-pmid 20631142?>
  <pub-id pub-id-type="pmid">20631142</pub-id>
 </element-citation>
</ref>
